Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Stockholders' Equity

v3.21.2
Consolidated Statements of Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Capital in Excess of Par
Retained Earnings (Accumulated Deficit)
Beginning balance (in shares) at Dec. 31, 2019 [1]   39,659    
Beginning balance at Dec. 31, 2019 $ 3,223,308 $ 3,966 $ 3,198,076 $ 21,266
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net loss 216,565     216,565
Restricted stock (in shares) [1]   14    
Restricted stock 3,142 $ 1 3,141  
Other (112)   (112)  
Ending balance (in shares) at Mar. 31, 2020 [1]   39,673    
Ending balance at Mar. 31, 2020 3,442,903 $ 3,967 3,201,105 237,831
Beginning balance (in shares) at Dec. 31, 2019 [1]   39,659    
Beginning balance at Dec. 31, 2019 3,223,308 $ 3,966 3,198,076 21,266
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net loss (2,028,550)      
Ending balance (in shares) at Sep. 30, 2020 [1]   39,750    
Ending balance at Sep. 30, 2020 1,204,104 $ 397 3,210,991 (2,007,284)
Beginning balance (in shares) at Mar. 31, 2020 [1]   39,673    
Beginning balance at Mar. 31, 2020 3,442,903 $ 3,967 3,201,105 237,831
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net loss (1,564,731)     (1,564,731)
Restricted stock (in shares) [1]   66    
Restricted stock 3,212 $ 7 3,205  
Ending balance (in shares) at Jun. 30, 2020 [1]   39,739    
Ending balance at Jun. 30, 2020 1,881,384 $ 3,974 3,204,310 (1,326,900)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net loss (680,384)     (680,384)
Restricted stock (in shares) [1]   11    
Restricted stock 3,009 $ 1 3,008  
Reverse stock split 0 $ (3,578) 3,578  
Other 95   95  
Ending balance (in shares) at Sep. 30, 2020 [1]   39,750    
Ending balance at Sep. 30, 2020 1,204,104 $ 397 3,210,991 (2,007,284)
Beginning balance (in shares) at Dec. 31, 2020   39,759    
Beginning balance at Dec. 31, 2020 711,002 $ 398 3,222,959 (2,512,355)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net loss (80,407)     (80,407)
Restricted stock (in shares)   13    
Restricted stock 2,609   2,609  
Warrant exercises (in shares)   6,385    
Warrant exercises 134,818 $ 64 134,754  
Ending balance (in shares) at Mar. 31, 2021   46,157    
Ending balance at Mar. 31, 2021 768,022 $ 462 3,360,322 (2,592,762)
Beginning balance (in shares) at Dec. 31, 2020   39,759    
Beginning balance at Dec. 31, 2020 711,002 $ 398 3,222,959 (2,512,355)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net loss 79,800      
Ending balance (in shares) at Sep. 30, 2021   46,291    
Ending balance at Sep. 30, 2021 933,029 $ 463 3,365,121 (2,432,555)
Beginning balance (in shares) at Mar. 31, 2021   46,157    
Beginning balance at Mar. 31, 2021 768,022 $ 462 3,360,322 (2,592,762)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net loss (11,695)     (11,695)
Restricted stock (in shares)   132    
Restricted stock 961 $ 1 960  
Ending balance (in shares) at Jun. 30, 2021   46,289    
Ending balance at Jun. 30, 2021 757,288 $ 463 3,361,282 (2,604,457)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net loss 171,902     171,902
Restricted stock (in shares)   2    
Restricted stock 3,839   3,839  
Ending balance (in shares) at Sep. 30, 2021   46,291    
Ending balance at Sep. 30, 2021 $ 933,029 $ 463 $ 3,365,121 $ (2,432,555)
[1] All share amounts have been retroactively adjusted for the Company’s 1-for-10 reverse stock split effective August 7, 2020. See “Note 11 - Stockholders’ Equity” of the Notes to Consolidated Financial Statements in its Annual Report on Form 10-K for the year ended December 31, 2020 for additional information.